These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19093337)

  • 1. A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care.
    Wong W
    Manag Care; 2008 Jul; 17(7 Suppl 7):13-6; discussion 17-8. PubMed ID: 19093337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing therapeutically developed assays.
    Kolesar JM
    Manag Care; 2008 Jul; 17(7 Suppl 7):9-12; discussion 17-8. PubMed ID: 19097282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
    Heaton AH
    Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers of breast axillary lymph node metastasis.
    Cavalli LR
    Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
    Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW
    Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How broadening DM's focus helped shrink one plan's costs.
    Gold WR; Kongstvedt P
    Manag Care; 2003 Nov; 12(11):33-4, 37-9. PubMed ID: 14666584
    [No Abstract]   [Full Text] [Related]  

  • 9. Can insurer, oncology practice really work together? Premera Blue Cross and a large Spokane oncology practice agree on treatment protocols and on the importance of cost control.
    Butcher L
    Manag Care; 2007 Oct; 16(10):45-6, 49. PubMed ID: 18018494
    [No Abstract]   [Full Text] [Related]  

  • 10. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blues plan's bold move brings generics savings.
    Sipkoff M
    Manag Care; 2006 Apr; 15(4):10-1. PubMed ID: 16686166
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational research and the changing face of breast cancer.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S1-2. PubMed ID: 15597214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Breast cancer and molecular markers].
    Ishioka C
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1261-8. PubMed ID: 18701834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of a gene expression profile on breast cancer decisions.
    Henry LR; Stojadinovic A; Swain SM; Prindiville S; Cordes R; Soballe PW
    J Surg Oncol; 2009 May; 99(6):319-23. PubMed ID: 19204954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling for managing breast cancer treatment.
    Technol Eval Cent Assess Program Exec Summ; 2005 May; 20(3):1-5. PubMed ID: 15940843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive health program aims to reduce cost, incidence of breast cancer.
    Capitation Manag Rep; 2000 Jan; 7(1):13-5. PubMed ID: 11183288
    [No Abstract]   [Full Text] [Related]  

  • 19. Upping the ante. Health plan betting on joint venture with Blues to change its luck in Atlantic City market.
    Pallarito K
    Mod Healthc; 1999 May; 29(18):10-1. PubMed ID: 10387836
    [No Abstract]   [Full Text] [Related]  

  • 20. Meet the new WellPoint. Providers wonder how they and their patients will have to change to cope with the biggest managed-care merger to date.
    Benko LB
    Mod Healthc; 2003 Nov; 33(44):6-7, 16, 1. PubMed ID: 14626583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.